nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC4—Rosuvastatin—atherosclerosis	0.109	0.159	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0403	0.0588	CbGbCtD
Sildenafil—CYP3A7—Simvastatin—atherosclerosis	0.0403	0.0588	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0395	0.0576	CbGbCtD
Sildenafil—CYP3A7—Lovastatin—atherosclerosis	0.0395	0.0576	CbGbCtD
Sildenafil—CYP3A5—Rosuvastatin—atherosclerosis	0.0325	0.0475	CbGbCtD
Sildenafil—CYP3A5—Simvastatin—atherosclerosis	0.0303	0.0441	CbGbCtD
Sildenafil—CYP3A5—Lovastatin—atherosclerosis	0.0296	0.0432	CbGbCtD
Sildenafil—CYP3A5—Pravastatin—atherosclerosis	0.0296	0.0432	CbGbCtD
Sildenafil—CYP2C19—Rosuvastatin—atherosclerosis	0.0263	0.0383	CbGbCtD
Sildenafil—CYP2C19—Simvastatin—atherosclerosis	0.0244	0.0356	CbGbCtD
Sildenafil—CYP2C19—Lovastatin—atherosclerosis	0.0239	0.0348	CbGbCtD
Sildenafil—CYP2D6—Niacin—atherosclerosis	0.0235	0.0342	CbGbCtD
Sildenafil—CYP2C9—Rosuvastatin—atherosclerosis	0.0218	0.0318	CbGbCtD
Sildenafil—CYP2C9—Simvastatin—atherosclerosis	0.0203	0.0296	CbGbCtD
Sildenafil—CYP2C9—Lovastatin—atherosclerosis	0.0199	0.029	CbGbCtD
Sildenafil—CYP2C9—Pravastatin—atherosclerosis	0.0199	0.029	CbGbCtD
Sildenafil—CYP2D6—Simvastatin—atherosclerosis	0.0186	0.0271	CbGbCtD
Sildenafil—CYP2D6—Pravastatin—atherosclerosis	0.0182	0.0265	CbGbCtD
Sildenafil—CYP2D6—Lovastatin—atherosclerosis	0.0182	0.0265	CbGbCtD
Sildenafil—CYP3A4—Ezetimibe—atherosclerosis	0.0127	0.0185	CbGbCtD
Sildenafil—CYP3A4—Rosuvastatin—atherosclerosis	0.0127	0.0185	CbGbCtD
Sildenafil—CYP3A4—Simvastatin—atherosclerosis	0.0118	0.0172	CbGbCtD
Sildenafil—CYP3A4—Lovastatin—atherosclerosis	0.0115	0.0168	CbGbCtD
Sildenafil—CYP3A4—Pravastatin—atherosclerosis	0.0115	0.0168	CbGbCtD
Sildenafil—PDE5A—penis—atherosclerosis	0.0051	0.22	CbGeAlD
Sildenafil—PDE5A—artery—atherosclerosis	0.00236	0.102	CbGeAlD
Sildenafil—PDE5A—endothelium—atherosclerosis	0.00199	0.0861	CbGeAlD
Sildenafil—PDE5A—blood vessel—atherosclerosis	0.00184	0.0794	CbGeAlD
Sildenafil—PDE6G—liver—atherosclerosis	0.00128	0.0554	CbGeAlD
Sildenafil—PDE5A—connective tissue—atherosclerosis	0.000942	0.0407	CbGeAlD
Sildenafil—ADORA2A—cardiovascular system—atherosclerosis	0.0009	0.0389	CbGeAlD
Sildenafil—PDE5A—cardiovascular system—atherosclerosis	0.00082	0.0354	CbGeAlD
Sildenafil—PDE5A—adipose tissue—atherosclerosis	0.000723	0.0312	CbGeAlD
Sildenafil—ABCC5—adipose tissue—atherosclerosis	0.000661	0.0286	CbGeAlD
Sildenafil—CYP3A7—liver—atherosclerosis	0.000598	0.0259	CbGeAlD
Sildenafil—ADORA2A—liver—atherosclerosis	0.000557	0.0241	CbGeAlD
Sildenafil—ABCC10—adipose tissue—atherosclerosis	0.000553	0.0239	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000509	0.022	CbGeAlD
Sildenafil—ABCC5—liver—atherosclerosis	0.000464	0.02	CbGeAlD
Sildenafil—ABCC4—adipose tissue—atherosclerosis	0.000458	0.0198	CbGeAlD
Sildenafil—ABCC10—liver—atherosclerosis	0.000387	0.0167	CbGeAlD
Sildenafil—Visual impairment—Niacin—atherosclerosis	0.000354	0.00192	CcSEcCtD
Sildenafil—Alopecia—Simvastatin—atherosclerosis	0.000354	0.00191	CcSEcCtD
Sildenafil—Back pain—Ezetimibe—atherosclerosis	0.000354	0.00191	CcSEcCtD
Sildenafil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000352	0.0019	CcSEcCtD
Sildenafil—Vision blurred—Lovastatin—atherosclerosis	0.000351	0.0019	CcSEcCtD
Sildenafil—Mental disorder—Simvastatin—atherosclerosis	0.000351	0.0019	CcSEcCtD
Sildenafil—Tremor—Lovastatin—atherosclerosis	0.000349	0.00189	CcSEcCtD
Sildenafil—Visual impairment—Pravastatin—atherosclerosis	0.000349	0.00189	CcSEcCtD
Sildenafil—Erythema—Simvastatin—atherosclerosis	0.000349	0.00189	CcSEcCtD
Sildenafil—Ill-defined disorder—Lovastatin—atherosclerosis	0.000346	0.00187	CcSEcCtD
Sildenafil—Eye disorder—Niacin—atherosclerosis	0.000344	0.00186	CcSEcCtD
Sildenafil—Flatulence—Simvastatin—atherosclerosis	0.000344	0.00186	CcSEcCtD
Sildenafil—Tinnitus—Niacin—atherosclerosis	0.000343	0.00186	CcSEcCtD
Sildenafil—Erythema multiforme—Pravastatin—atherosclerosis	0.000342	0.00185	CcSEcCtD
Sildenafil—Flushing—Niacin—atherosclerosis	0.000341	0.00185	CcSEcCtD
Sildenafil—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000339	0.00184	CcSEcCtD
Sildenafil—Anaemia—Ezetimibe—atherosclerosis	0.000338	0.00183	CcSEcCtD
Sildenafil—Tinnitus—Pravastatin—atherosclerosis	0.000338	0.00183	CcSEcCtD
Sildenafil—Malaise—Lovastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Sildenafil—Cardiac disorder—Pravastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Sildenafil—Flushing—Pravastatin—atherosclerosis	0.000336	0.00182	CcSEcCtD
Sildenafil—CYP2C9—cardiovascular system—atherosclerosis	0.000335	0.0145	CbGeAlD
Sildenafil—Vertigo—Lovastatin—atherosclerosis	0.000335	0.00181	CcSEcCtD
Sildenafil—Angiopathy—Niacin—atherosclerosis	0.000334	0.00181	CcSEcCtD
Sildenafil—Leukopenia—Lovastatin—atherosclerosis	0.000334	0.00181	CcSEcCtD
Sildenafil—Chills—Niacin—atherosclerosis	0.00033	0.00179	CcSEcCtD
Sildenafil—Malaise—Ezetimibe—atherosclerosis	0.00033	0.00178	CcSEcCtD
Sildenafil—Vision blurred—Simvastatin—atherosclerosis	0.000329	0.00178	CcSEcCtD
Sildenafil—Arrhythmia—Niacin—atherosclerosis	0.000329	0.00178	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000327	0.00177	CcSEcCtD
Sildenafil—Tremor—Simvastatin—atherosclerosis	0.000327	0.00177	CcSEcCtD
Sildenafil—Alopecia—Niacin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Sildenafil—Chills—Pravastatin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Sildenafil—Insomnia—Rosuvastatin—atherosclerosis	0.000325	0.00176	CcSEcCtD
Sildenafil—Ill-defined disorder—Simvastatin—atherosclerosis	0.000323	0.00175	CcSEcCtD
Sildenafil—Arrhythmia—Pravastatin—atherosclerosis	0.000323	0.00175	CcSEcCtD
Sildenafil—Palpitations—Ezetimibe—atherosclerosis	0.000323	0.00175	CcSEcCtD
Sildenafil—Paraesthesia—Rosuvastatin—atherosclerosis	0.000322	0.00174	CcSEcCtD
Sildenafil—Anaemia—Simvastatin—atherosclerosis	0.000322	0.00174	CcSEcCtD
Sildenafil—ABCC4—liver—atherosclerosis	0.000321	0.0139	CbGeAlD
Sildenafil—Malnutrition—Niacin—atherosclerosis	0.00032	0.00173	CcSEcCtD
Sildenafil—Erythema—Niacin—atherosclerosis	0.00032	0.00173	CcSEcCtD
Sildenafil—Alopecia—Pravastatin—atherosclerosis	0.00032	0.00173	CcSEcCtD
Sildenafil—Cough—Ezetimibe—atherosclerosis	0.000319	0.00173	CcSEcCtD
Sildenafil—CYP2E1—cardiovascular system—atherosclerosis	0.000318	0.0137	CbGeAlD
Sildenafil—Chest pain—Lovastatin—atherosclerosis	0.000317	0.00172	CcSEcCtD
Sildenafil—Arthralgia—Lovastatin—atherosclerosis	0.000317	0.00172	CcSEcCtD
Sildenafil—Myalgia—Lovastatin—atherosclerosis	0.000317	0.00172	CcSEcCtD
Sildenafil—Anxiety—Lovastatin—atherosclerosis	0.000316	0.00171	CcSEcCtD
Sildenafil—Dyspepsia—Rosuvastatin—atherosclerosis	0.000316	0.00171	CcSEcCtD
Sildenafil—Hypertension—Ezetimibe—atherosclerosis	0.000316	0.00171	CcSEcCtD
Sildenafil—Flatulence—Niacin—atherosclerosis	0.000315	0.00171	CcSEcCtD
Sildenafil—Malaise—Simvastatin—atherosclerosis	0.000314	0.0017	CcSEcCtD
Sildenafil—Tension—Niacin—atherosclerosis	0.000314	0.0017	CcSEcCtD
Sildenafil—Discomfort—Lovastatin—atherosclerosis	0.000314	0.0017	CcSEcCtD
Sildenafil—Vertigo—Simvastatin—atherosclerosis	0.000313	0.00169	CcSEcCtD
Sildenafil—Leukopenia—Simvastatin—atherosclerosis	0.000312	0.00169	CcSEcCtD
Sildenafil—Myalgia—Ezetimibe—atherosclerosis	0.000311	0.00168	CcSEcCtD
Sildenafil—Arthralgia—Ezetimibe—atherosclerosis	0.000311	0.00168	CcSEcCtD
Sildenafil—Chest pain—Ezetimibe—atherosclerosis	0.000311	0.00168	CcSEcCtD
Sildenafil—Nervousness—Niacin—atherosclerosis	0.000311	0.00168	CcSEcCtD
Sildenafil—Flatulence—Pravastatin—atherosclerosis	0.000311	0.00168	CcSEcCtD
Sildenafil—Dry mouth—Lovastatin—atherosclerosis	0.00031	0.00168	CcSEcCtD
Sildenafil—Tension—Pravastatin—atherosclerosis	0.000309	0.00167	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000309	0.00167	CcSEcCtD
Sildenafil—Discomfort—Ezetimibe—atherosclerosis	0.000308	0.00166	CcSEcCtD
Sildenafil—CYP1A1—adipose tissue—atherosclerosis	0.000307	0.0133	CbGeAlD
Sildenafil—Constipation—Rosuvastatin—atherosclerosis	0.000307	0.00166	CcSEcCtD
Sildenafil—Pain—Rosuvastatin—atherosclerosis	0.000307	0.00166	CcSEcCtD
Sildenafil—Nervousness—Pravastatin—atherosclerosis	0.000306	0.00166	CcSEcCtD
Sildenafil—Dry mouth—Ezetimibe—atherosclerosis	0.000304	0.00165	CcSEcCtD
Sildenafil—Infection—Lovastatin—atherosclerosis	0.000302	0.00164	CcSEcCtD
Sildenafil—Vision blurred—Niacin—atherosclerosis	0.000302	0.00163	CcSEcCtD
Sildenafil—CYP3A5—adipose tissue—atherosclerosis	0.0003	0.013	CbGeAlD
Sildenafil—Vision blurred—Pravastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Sildenafil—Chest pain—Simvastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Sildenafil—Myalgia—Simvastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Sildenafil—Arthralgia—Simvastatin—atherosclerosis	0.000297	0.00161	CcSEcCtD
Sildenafil—Infection—Ezetimibe—atherosclerosis	0.000296	0.0016	CcSEcCtD
Sildenafil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000296	0.0016	CcSEcCtD
Sildenafil—Anxiety—Simvastatin—atherosclerosis	0.000296	0.0016	CcSEcCtD
Sildenafil—Tremor—Pravastatin—atherosclerosis	0.000295	0.0016	CcSEcCtD
Sildenafil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000294	0.00159	CcSEcCtD
Sildenafil—Discomfort—Simvastatin—atherosclerosis	0.000293	0.00159	CcSEcCtD
Sildenafil—Nervous system disorder—Ezetimibe—atherosclerosis	0.000293	0.00158	CcSEcCtD
Sildenafil—Ill-defined disorder—Pravastatin—atherosclerosis	0.000292	0.00158	CcSEcCtD
Sildenafil—Anaemia—Pravastatin—atherosclerosis	0.000291	0.00158	CcSEcCtD
Sildenafil—Anorexia—Lovastatin—atherosclerosis	0.00029	0.00157	CcSEcCtD
Sildenafil—Skin disorder—Ezetimibe—atherosclerosis	0.00029	0.00157	CcSEcCtD
Sildenafil—Vertigo—Niacin—atherosclerosis	0.000288	0.00156	CcSEcCtD
Sildenafil—Syncope—Niacin—atherosclerosis	0.000287	0.00155	CcSEcCtD
Sildenafil—Leukopenia—Niacin—atherosclerosis	0.000287	0.00155	CcSEcCtD
Sildenafil—Urticaria—Rosuvastatin—atherosclerosis	0.000285	0.00154	CcSEcCtD
Sildenafil—Oedema—Simvastatin—atherosclerosis	0.000285	0.00154	CcSEcCtD
Sildenafil—Malaise—Pravastatin—atherosclerosis	0.000284	0.00154	CcSEcCtD
Sildenafil—Abdominal pain—Rosuvastatin—atherosclerosis	0.000284	0.00154	CcSEcCtD
Sildenafil—Vertigo—Pravastatin—atherosclerosis	0.000283	0.00153	CcSEcCtD
Sildenafil—Palpitations—Niacin—atherosclerosis	0.000283	0.00153	CcSEcCtD
Sildenafil—Infection—Simvastatin—atherosclerosis	0.000283	0.00153	CcSEcCtD
Sildenafil—Leukopenia—Pravastatin—atherosclerosis	0.000282	0.00153	CcSEcCtD
Sildenafil—Loss of consciousness—Niacin—atherosclerosis	0.000281	0.00152	CcSEcCtD
Sildenafil—Cough—Niacin—atherosclerosis	0.000279	0.00151	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000277	0.0015	CcSEcCtD
Sildenafil—Insomnia—Lovastatin—atherosclerosis	0.000275	0.00149	CcSEcCtD
Sildenafil—Cough—Pravastatin—atherosclerosis	0.000275	0.00149	CcSEcCtD
Sildenafil—Paraesthesia—Lovastatin—atherosclerosis	0.000273	0.00148	CcSEcCtD
Sildenafil—Myalgia—Niacin—atherosclerosis	0.000273	0.00147	CcSEcCtD
Sildenafil—Arthralgia—Niacin—atherosclerosis	0.000273	0.00147	CcSEcCtD
Sildenafil—Hypertension—Pravastatin—atherosclerosis	0.000272	0.00147	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000272	0.00147	CcSEcCtD
Sildenafil—Anorexia—Simvastatin—atherosclerosis	0.000271	0.00147	CcSEcCtD
Sildenafil—Dyspnoea—Lovastatin—atherosclerosis	0.000271	0.00147	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000271	0.00146	CcSEcCtD
Sildenafil—Insomnia—Ezetimibe—atherosclerosis	0.00027	0.00146	CcSEcCtD
Sildenafil—Myalgia—Pravastatin—atherosclerosis	0.000268	0.00145	CcSEcCtD
Sildenafil—Arthralgia—Pravastatin—atherosclerosis	0.000268	0.00145	CcSEcCtD
Sildenafil—Chest pain—Pravastatin—atherosclerosis	0.000268	0.00145	CcSEcCtD
Sildenafil—Paraesthesia—Ezetimibe—atherosclerosis	0.000268	0.00145	CcSEcCtD
Sildenafil—Dyspepsia—Lovastatin—atherosclerosis	0.000268	0.00145	CcSEcCtD
Sildenafil—Anxiety—Pravastatin—atherosclerosis	0.000267	0.00145	CcSEcCtD
Sildenafil—CYP2C19—liver—atherosclerosis	0.000267	0.0116	CbGeAlD
Sildenafil—Dry mouth—Niacin—atherosclerosis	0.000267	0.00144	CcSEcCtD
Sildenafil—Dyspnoea—Ezetimibe—atherosclerosis	0.000266	0.00144	CcSEcCtD
Sildenafil—Discomfort—Pravastatin—atherosclerosis	0.000265	0.00143	CcSEcCtD
Sildenafil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000264	0.00143	CcSEcCtD
Sildenafil—Decreased appetite—Lovastatin—atherosclerosis	0.000264	0.00143	CcSEcCtD
Sildenafil—Dyspepsia—Ezetimibe—atherosclerosis	0.000263	0.00142	CcSEcCtD
Sildenafil—Fatigue—Lovastatin—atherosclerosis	0.000262	0.00142	CcSEcCtD
Sildenafil—Oedema—Niacin—atherosclerosis	0.000261	0.00141	CcSEcCtD
Sildenafil—Pain—Lovastatin—atherosclerosis	0.00026	0.00141	CcSEcCtD
Sildenafil—Constipation—Lovastatin—atherosclerosis	0.00026	0.00141	CcSEcCtD
Sildenafil—Decreased appetite—Ezetimibe—atherosclerosis	0.000259	0.0014	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000259	0.0014	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000258	0.00139	CcSEcCtD
Sildenafil—Asthenia—Rosuvastatin—atherosclerosis	0.000258	0.00139	CcSEcCtD
Sildenafil—Insomnia—Simvastatin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Sildenafil—Oedema—Pravastatin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Sildenafil—Fatigue—Ezetimibe—atherosclerosis	0.000257	0.00139	CcSEcCtD
Sildenafil—Shock—Niacin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Sildenafil—Infection—Pravastatin—atherosclerosis	0.000256	0.00138	CcSEcCtD
Sildenafil—Paraesthesia—Simvastatin—atherosclerosis	0.000255	0.00138	CcSEcCtD
Sildenafil—Constipation—Ezetimibe—atherosclerosis	0.000255	0.00138	CcSEcCtD
Sildenafil—Pain—Ezetimibe—atherosclerosis	0.000255	0.00138	CcSEcCtD
Sildenafil—Tachycardia—Niacin—atherosclerosis	0.000255	0.00138	CcSEcCtD
Sildenafil—Pruritus—Rosuvastatin—atherosclerosis	0.000254	0.00137	CcSEcCtD
Sildenafil—Skin disorder—Niacin—atherosclerosis	0.000254	0.00137	CcSEcCtD
Sildenafil—Dyspnoea—Simvastatin—atherosclerosis	0.000254	0.00137	CcSEcCtD
Sildenafil—Hyperhidrosis—Niacin—atherosclerosis	0.000253	0.00137	CcSEcCtD
Sildenafil—Feeling abnormal—Lovastatin—atherosclerosis	0.000251	0.00136	CcSEcCtD
Sildenafil—Dyspepsia—Simvastatin—atherosclerosis	0.00025	0.00136	CcSEcCtD
Sildenafil—Anorexia—Niacin—atherosclerosis	0.000249	0.00135	CcSEcCtD
Sildenafil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000249	0.00135	CcSEcCtD
Sildenafil—Hyperhidrosis—Pravastatin—atherosclerosis	0.000249	0.00135	CcSEcCtD
Sildenafil—Decreased appetite—Simvastatin—atherosclerosis	0.000247	0.00134	CcSEcCtD
Sildenafil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000246	0.00133	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000246	0.00133	CcSEcCtD
Sildenafil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000246	0.00133	CcSEcCtD
Sildenafil—Fatigue—Simvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Sildenafil—Anorexia—Pravastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Sildenafil—Hypotension—Niacin—atherosclerosis	0.000244	0.00132	CcSEcCtD
Sildenafil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000244	0.00132	CcSEcCtD
Sildenafil—Constipation—Simvastatin—atherosclerosis	0.000243	0.00132	CcSEcCtD
Sildenafil—Pain—Simvastatin—atherosclerosis	0.000243	0.00132	CcSEcCtD
Sildenafil—Urticaria—Lovastatin—atherosclerosis	0.000242	0.00131	CcSEcCtD
Sildenafil—Abdominal pain—Lovastatin—atherosclerosis	0.00024	0.0013	CcSEcCtD
Sildenafil—Body temperature increased—Lovastatin—atherosclerosis	0.00024	0.0013	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000238	0.00129	CcSEcCtD
Sildenafil—Dizziness—Rosuvastatin—atherosclerosis	0.000237	0.00128	CcSEcCtD
Sildenafil—Urticaria—Ezetimibe—atherosclerosis	0.000237	0.00128	CcSEcCtD
Sildenafil—Insomnia—Niacin—atherosclerosis	0.000236	0.00128	CcSEcCtD
Sildenafil—Abdominal pain—Ezetimibe—atherosclerosis	0.000236	0.00128	CcSEcCtD
Sildenafil—Body temperature increased—Ezetimibe—atherosclerosis	0.000236	0.00128	CcSEcCtD
Sildenafil—Paraesthesia—Niacin—atherosclerosis	0.000235	0.00127	CcSEcCtD
Sildenafil—Feeling abnormal—Simvastatin—atherosclerosis	0.000234	0.00127	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000234	0.00127	CcSEcCtD
Sildenafil—Dyspnoea—Niacin—atherosclerosis	0.000233	0.00126	CcSEcCtD
Sildenafil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000233	0.00126	CcSEcCtD
Sildenafil—Insomnia—Pravastatin—atherosclerosis	0.000233	0.00126	CcSEcCtD
Sildenafil—Somnolence—Niacin—atherosclerosis	0.000232	0.00126	CcSEcCtD
Sildenafil—Paraesthesia—Pravastatin—atherosclerosis	0.000231	0.00125	CcSEcCtD
Sildenafil—Dyspepsia—Niacin—atherosclerosis	0.00023	0.00124	CcSEcCtD
Sildenafil—Dyspnoea—Pravastatin—atherosclerosis	0.000229	0.00124	CcSEcCtD
Sildenafil—Decreased appetite—Niacin—atherosclerosis	0.000227	0.00123	CcSEcCtD
Sildenafil—Dyspepsia—Pravastatin—atherosclerosis	0.000226	0.00123	CcSEcCtD
Sildenafil—Rash—Rosuvastatin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Sildenafil—Dermatitis—Rosuvastatin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Sildenafil—Urticaria—Simvastatin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Niacin—atherosclerosis	0.000226	0.00122	CcSEcCtD
Sildenafil—Body temperature increased—Simvastatin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Sildenafil—Abdominal pain—Simvastatin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Sildenafil—Headache—Rosuvastatin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Sildenafil—Hypersensitivity—Lovastatin—atherosclerosis	0.000224	0.00121	CcSEcCtD
Sildenafil—Decreased appetite—Pravastatin—atherosclerosis	0.000224	0.00121	CcSEcCtD
Sildenafil—Pain—Niacin—atherosclerosis	0.000223	0.00121	CcSEcCtD
Sildenafil—Fatigue—Pravastatin—atherosclerosis	0.000222	0.0012	CcSEcCtD
Sildenafil—Constipation—Pravastatin—atherosclerosis	0.00022	0.00119	CcSEcCtD
Sildenafil—Pain—Pravastatin—atherosclerosis	0.00022	0.00119	CcSEcCtD
Sildenafil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00022	0.00119	CcSEcCtD
Sildenafil—Asthenia—Lovastatin—atherosclerosis	0.000218	0.00118	CcSEcCtD
Sildenafil—CYP1A1—liver—atherosclerosis	0.000215	0.00931	CbGeAlD
Sildenafil—Pruritus—Lovastatin—atherosclerosis	0.000215	0.00116	CcSEcCtD
Sildenafil—Asthenia—Ezetimibe—atherosclerosis	0.000214	0.00116	CcSEcCtD
Sildenafil—Gastrointestinal pain—Niacin—atherosclerosis	0.000214	0.00116	CcSEcCtD
Sildenafil—Nausea—Rosuvastatin—atherosclerosis	0.000213	0.00115	CcSEcCtD
Sildenafil—Feeling abnormal—Pravastatin—atherosclerosis	0.000212	0.00115	CcSEcCtD
Sildenafil—Pruritus—Ezetimibe—atherosclerosis	0.000211	0.00114	CcSEcCtD
Sildenafil—CYP3A5—liver—atherosclerosis	0.000211	0.0091	CbGeAlD
Sildenafil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00021	0.00114	CcSEcCtD
Sildenafil—Hypersensitivity—Simvastatin—atherosclerosis	0.00021	0.00113	CcSEcCtD
Sildenafil—Diarrhoea—Lovastatin—atherosclerosis	0.000208	0.00113	CcSEcCtD
Sildenafil—Urticaria—Niacin—atherosclerosis	0.000208	0.00112	CcSEcCtD
Sildenafil—CYP2C9—liver—atherosclerosis	0.000207	0.00896	CbGeAlD
Sildenafil—Abdominal pain—Niacin—atherosclerosis	0.000207	0.00112	CcSEcCtD
Sildenafil—Body temperature increased—Niacin—atherosclerosis	0.000207	0.00112	CcSEcCtD
Sildenafil—Urticaria—Pravastatin—atherosclerosis	0.000204	0.00111	CcSEcCtD
Sildenafil—Asthenia—Simvastatin—atherosclerosis	0.000204	0.0011	CcSEcCtD
Sildenafil—Diarrhoea—Ezetimibe—atherosclerosis	0.000204	0.0011	CcSEcCtD
Sildenafil—Abdominal pain—Pravastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Sildenafil—Body temperature increased—Pravastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Sildenafil—Pruritus—Simvastatin—atherosclerosis	0.000201	0.00109	CcSEcCtD
Sildenafil—Dizziness—Lovastatin—atherosclerosis	0.000201	0.00109	CcSEcCtD
Sildenafil—Dizziness—Ezetimibe—atherosclerosis	0.000197	0.00107	CcSEcCtD
Sildenafil—CYP2E1—liver—atherosclerosis	0.000196	0.00849	CbGeAlD
Sildenafil—Diarrhoea—Simvastatin—atherosclerosis	0.000195	0.00105	CcSEcCtD
Sildenafil—Vomiting—Lovastatin—atherosclerosis	0.000193	0.00105	CcSEcCtD
Sildenafil—Hypersensitivity—Niacin—atherosclerosis	0.000192	0.00104	CcSEcCtD
Sildenafil—Rash—Lovastatin—atherosclerosis	0.000192	0.00104	CcSEcCtD
Sildenafil—Dermatitis—Lovastatin—atherosclerosis	0.000192	0.00104	CcSEcCtD
Sildenafil—Headache—Lovastatin—atherosclerosis	0.000191	0.00103	CcSEcCtD
Sildenafil—Vomiting—Ezetimibe—atherosclerosis	0.00019	0.00103	CcSEcCtD
Sildenafil—Hypersensitivity—Pravastatin—atherosclerosis	0.00019	0.00103	CcSEcCtD
Sildenafil—Dizziness—Simvastatin—atherosclerosis	0.000188	0.00102	CcSEcCtD
Sildenafil—Rash—Ezetimibe—atherosclerosis	0.000188	0.00102	CcSEcCtD
Sildenafil—Dermatitis—Ezetimibe—atherosclerosis	0.000188	0.00102	CcSEcCtD
Sildenafil—Asthenia—Niacin—atherosclerosis	0.000187	0.00101	CcSEcCtD
Sildenafil—Headache—Ezetimibe—atherosclerosis	0.000187	0.00101	CcSEcCtD
Sildenafil—Pruritus—Niacin—atherosclerosis	0.000185	0.001	CcSEcCtD
Sildenafil—Asthenia—Pravastatin—atherosclerosis	0.000185	0.000999	CcSEcCtD
Sildenafil—Pruritus—Pravastatin—atherosclerosis	0.000182	0.000985	CcSEcCtD
Sildenafil—Vomiting—Simvastatin—atherosclerosis	0.000181	0.000979	CcSEcCtD
Sildenafil—Nausea—Lovastatin—atherosclerosis	0.000181	0.000978	CcSEcCtD
Sildenafil—Rash—Simvastatin—atherosclerosis	0.000179	0.000971	CcSEcCtD
Sildenafil—Dermatitis—Simvastatin—atherosclerosis	0.000179	0.00097	CcSEcCtD
Sildenafil—Diarrhoea—Niacin—atherosclerosis	0.000179	0.000967	CcSEcCtD
Sildenafil—Headache—Simvastatin—atherosclerosis	0.000178	0.000964	CcSEcCtD
Sildenafil—Nausea—Ezetimibe—atherosclerosis	0.000177	0.000959	CcSEcCtD
Sildenafil—Diarrhoea—Pravastatin—atherosclerosis	0.000176	0.000952	CcSEcCtD
Sildenafil—Dizziness—Niacin—atherosclerosis	0.000173	0.000935	CcSEcCtD
Sildenafil—Dizziness—Pravastatin—atherosclerosis	0.00017	0.00092	CcSEcCtD
Sildenafil—Nausea—Simvastatin—atherosclerosis	0.000169	0.000914	CcSEcCtD
Sildenafil—Vomiting—Niacin—atherosclerosis	0.000166	0.000899	CcSEcCtD
Sildenafil—Rash—Niacin—atherosclerosis	0.000165	0.000891	CcSEcCtD
Sildenafil—Dermatitis—Niacin—atherosclerosis	0.000165	0.00089	CcSEcCtD
Sildenafil—Headache—Niacin—atherosclerosis	0.000164	0.000886	CcSEcCtD
Sildenafil—Vomiting—Pravastatin—atherosclerosis	0.000164	0.000885	CcSEcCtD
Sildenafil—Rash—Pravastatin—atherosclerosis	0.000162	0.000878	CcSEcCtD
Sildenafil—Dermatitis—Pravastatin—atherosclerosis	0.000162	0.000877	CcSEcCtD
Sildenafil—Headache—Pravastatin—atherosclerosis	0.000161	0.000872	CcSEcCtD
Sildenafil—CYP3A4—liver—atherosclerosis	0.000158	0.00683	CbGeAlD
Sildenafil—CYP2D6—liver—atherosclerosis	0.000156	0.00672	CbGeAlD
Sildenafil—Nausea—Niacin—atherosclerosis	0.000155	0.00084	CcSEcCtD
Sildenafil—Nausea—Pravastatin—atherosclerosis	0.000153	0.000827	CcSEcCtD
Sildenafil—CYP2D6—Metabolism—APOA5—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.07e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOA5—atherosclerosis	1.06e-05	0.0001	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.06e-05	9.99e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—LPL—atherosclerosis	1.06e-05	9.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.05e-05	9.85e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—atherosclerosis	1.04e-05	9.76e-05	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—atherosclerosis	1.03e-05	9.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.03e-05	9.71e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.03e-05	9.71e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.03e-05	9.69e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GPX1—atherosclerosis	1.03e-05	9.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.02e-05	9.62e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—atherosclerosis	1.02e-05	9.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.01e-05	9.51e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—atherosclerosis	1e-05	9.43e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1e-05	9.43e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CD36—atherosclerosis	1e-05	9.43e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1e-05	9.42e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1e-05	9.41e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALOX5—atherosclerosis	9.98e-06	9.38e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—INS—atherosclerosis	9.92e-06	9.32e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.89e-06	9.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCL2—atherosclerosis	9.76e-06	9.17e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCA1—atherosclerosis	9.74e-06	9.16e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NAMPT—atherosclerosis	9.73e-06	9.14e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.72e-06	9.14e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.67e-06	9.09e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—LIPC—atherosclerosis	9.67e-06	9.09e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.66e-06	9.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOC3—atherosclerosis	9.61e-06	9.03e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1—atherosclerosis	9.59e-06	9.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—LDLR—atherosclerosis	9.55e-06	8.97e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MTHFR—atherosclerosis	9.5e-06	8.93e-05	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—atherosclerosis	9.37e-06	8.8e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CETP—atherosclerosis	9.33e-06	8.77e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARA—atherosclerosis	9.33e-06	8.76e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.3e-06	8.74e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCA1—atherosclerosis	9.19e-06	8.63e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.14e-06	8.59e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SERPINE1—atherosclerosis	9.11e-06	8.56e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FABP4—atherosclerosis	9.08e-06	8.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LCAT—atherosclerosis	9.08e-06	8.53e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AGT—atherosclerosis	9.03e-06	8.49e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.95e-06	8.41e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SCARB1—atherosclerosis	8.93e-06	8.39e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA4—atherosclerosis	8.91e-06	8.37e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—LIPC—atherosclerosis	8.89e-06	8.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.87e-06	8.34e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—atherosclerosis	8.85e-06	8.32e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOC3—atherosclerosis	8.84e-06	8.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.82e-06	8.29e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—LIPC—atherosclerosis	8.82e-06	8.28e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—LDLR—atherosclerosis	8.78e-06	8.25e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CAV1—atherosclerosis	8.77e-06	8.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOC3—atherosclerosis	8.76e-06	8.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.75e-06	8.23e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOA1—atherosclerosis	8.75e-06	8.22e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—LDLR—atherosclerosis	8.71e-06	8.18e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOS3—atherosclerosis	8.7e-06	8.17e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.7e-06	8.17e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CETP—atherosclerosis	8.58e-06	8.06e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CETP—atherosclerosis	8.5e-06	7.99e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMGCR—atherosclerosis	8.44e-06	7.93e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—atherosclerosis	8.36e-06	7.86e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—atherosclerosis	8.34e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SCARB1—atherosclerosis	8.22e-06	7.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SCARB1—atherosclerosis	8.14e-06	7.65e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	8.09e-06	7.6e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOB—atherosclerosis	8.01e-06	7.53e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOB—atherosclerosis	7.99e-06	7.51e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.99e-06	7.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.93e-06	7.45e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—atherosclerosis	7.88e-06	7.41e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—atherosclerosis	7.83e-06	7.36e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—atherosclerosis	7.79e-06	7.32e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.77e-06	7.31e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.76e-06	7.29e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	7.71e-06	7.25e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—atherosclerosis	7.71e-06	7.24e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.69e-06	7.23e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA2—atherosclerosis	7.67e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.67e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.67e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.67e-06	7.21e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—LPL—atherosclerosis	7.65e-06	7.19e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—LPL—atherosclerosis	7.63e-06	7.17e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.61e-06	7.15e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.58e-06	7.12e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—INS—atherosclerosis	7.56e-06	7.1e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOB—atherosclerosis	7.55e-06	7.1e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.52e-06	7.07e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GPX1—atherosclerosis	7.46e-06	7.01e-05	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	7.45e-06	7e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GPX1—atherosclerosis	7.44e-06	7e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—atherosclerosis	7.34e-06	6.9e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	7.34e-06	6.89e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LPA—atherosclerosis	7.32e-06	6.88e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CD36—atherosclerosis	7.27e-06	6.83e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CD36—atherosclerosis	7.25e-06	6.81e-05	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—atherosclerosis	7.22e-06	6.79e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—LPL—atherosclerosis	7.21e-06	6.78e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BGN—atherosclerosis	7.09e-06	6.66e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GPX1—atherosclerosis	7.03e-06	6.61e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA5—atherosclerosis	7.02e-06	6.59e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	6.98e-06	6.56e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.94e-06	6.52e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—atherosclerosis	6.93e-06	6.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.92e-06	6.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	6.9e-06	6.49e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MTHFR—atherosclerosis	6.88e-06	6.47e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.87e-06	6.46e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.86e-06	6.44e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CD36—atherosclerosis	6.85e-06	6.44e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	6.79e-06	6.38e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	6.77e-06	6.36e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARA—atherosclerosis	6.75e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.75e-06	6.35e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARA—atherosclerosis	6.74e-06	6.33e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NOS3—atherosclerosis	6.63e-06	6.23e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AGT—atherosclerosis	6.54e-06	6.15e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AGT—atherosclerosis	6.53e-06	6.14e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.52e-06	6.13e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MTHFR—atherosclerosis	6.49e-06	6.1e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.45e-06	6.06e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—atherosclerosis	6.41e-06	6.02e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—atherosclerosis	6.4e-06	6.01e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARA—atherosclerosis	6.37e-06	5.98e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CAV1—atherosclerosis	6.35e-06	5.97e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CAV1—atherosclerosis	6.34e-06	5.96e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOA1—atherosclerosis	6.34e-06	5.95e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOA1—atherosclerosis	6.32e-06	5.94e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	6.27e-06	5.89e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	6.2e-06	5.83e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOB—atherosclerosis	6.18e-06	5.81e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AGT—atherosclerosis	6.17e-06	5.8e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—atherosclerosis	6.06e-06	5.7e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—atherosclerosis	6.05e-06	5.68e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—atherosclerosis	6.04e-06	5.68e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—atherosclerosis	6.01e-06	5.65e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CAV1—atherosclerosis	5.99e-06	5.63e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOA1—atherosclerosis	5.97e-06	5.61e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.93e-06	5.58e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	5.93e-06	5.57e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—LPL—atherosclerosis	5.9e-06	5.54e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.88e-06	5.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.85e-06	5.5e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LIPC—atherosclerosis	5.81e-06	5.46e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—atherosclerosis	5.78e-06	5.44e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOC3—atherosclerosis	5.78e-06	5.43e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.77e-06	5.42e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GPX1—atherosclerosis	5.76e-06	5.41e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	5.75e-06	5.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LDLR—atherosclerosis	5.74e-06	5.4e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOB—atherosclerosis	5.68e-06	5.34e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOB—atherosclerosis	5.63e-06	5.29e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CETP—atherosclerosis	5.61e-06	5.27e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CD36—atherosclerosis	5.61e-06	5.27e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—atherosclerosis	5.58e-06	5.25e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—atherosclerosis	5.57e-06	5.24e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.53e-06	5.2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.48e-06	5.15e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—INS—atherosclerosis	5.48e-06	5.15e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—INS—atherosclerosis	5.46e-06	5.14e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—atherosclerosis	5.45e-06	5.13e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—LPL—atherosclerosis	5.43e-06	5.1e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—LPL—atherosclerosis	5.38e-06	5.06e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.37e-06	5.05e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.31e-06	4.99e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GPX1—atherosclerosis	5.29e-06	4.98e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—atherosclerosis	5.26e-06	4.95e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GPX1—atherosclerosis	5.25e-06	4.93e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARA—atherosclerosis	5.21e-06	4.9e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—INS—atherosclerosis	5.16e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CD36—atherosclerosis	5.16e-06	4.85e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CD36—atherosclerosis	5.11e-06	4.8e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.07e-06	4.77e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AGT—atherosclerosis	5.05e-06	4.74e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—atherosclerosis	5.02e-06	4.72e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—atherosclerosis	5.01e-06	4.71e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—atherosclerosis	4.95e-06	4.65e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CAV1—atherosclerosis	4.9e-06	4.6e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOA1—atherosclerosis	4.89e-06	4.59e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.89e-06	4.59e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.84e-06	4.55e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NOS3—atherosclerosis	4.8e-06	4.51e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARA—atherosclerosis	4.79e-06	4.5e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NOS3—atherosclerosis	4.79e-06	4.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARA—atherosclerosis	4.75e-06	4.47e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—atherosclerosis	4.73e-06	4.45e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AGT—atherosclerosis	4.64e-06	4.36e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AGT—atherosclerosis	4.6e-06	4.32e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—atherosclerosis	4.55e-06	4.27e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NOS3—atherosclerosis	4.53e-06	4.25e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.52e-06	4.25e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—atherosclerosis	4.51e-06	4.24e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CAV1—atherosclerosis	4.51e-06	4.24e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOA1—atherosclerosis	4.5e-06	4.23e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CAV1—atherosclerosis	4.47e-06	4.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.46e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOA1—atherosclerosis	4.46e-06	4.19e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—atherosclerosis	4.39e-06	4.13e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.38e-06	4.12e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—atherosclerosis	4.33e-06	4.07e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—atherosclerosis	4.31e-06	4.05e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—INS—atherosclerosis	4.22e-06	3.97e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—atherosclerosis	4.14e-06	3.89e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.1e-06	3.86e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	4.07e-06	3.82e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	4e-06	3.76e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—atherosclerosis	3.96e-06	3.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—atherosclerosis	3.93e-06	3.69e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—INS—atherosclerosis	3.89e-06	3.65e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.88e-06	3.65e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—atherosclerosis	3.87e-06	3.64e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—INS—atherosclerosis	3.85e-06	3.62e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOB—atherosclerosis	3.72e-06	3.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NOS3—atherosclerosis	3.7e-06	3.48e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.61e-06	3.4e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—atherosclerosis	3.56e-06	3.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LPL—atherosclerosis	3.55e-06	3.33e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—atherosclerosis	3.53e-06	3.32e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPX1—atherosclerosis	3.46e-06	3.25e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NOS3—atherosclerosis	3.41e-06	3.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.39e-06	3.18e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NOS3—atherosclerosis	3.38e-06	3.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CD36—atherosclerosis	3.37e-06	3.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.19e-06	3e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARA—atherosclerosis	3.13e-06	2.94e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.12e-06	2.93e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—atherosclerosis	3.09e-06	2.9e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—atherosclerosis	3.05e-06	2.86e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AGT—atherosclerosis	3.04e-06	2.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—atherosclerosis	2.97e-06	2.79e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CAV1—atherosclerosis	2.95e-06	2.77e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOA1—atherosclerosis	2.94e-06	2.76e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.68e-06	2.52e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—atherosclerosis	2.59e-06	2.43e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—INS—atherosclerosis	2.54e-06	2.39e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—atherosclerosis	2.33e-06	2.19e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NOS3—atherosclerosis	2.23e-06	2.09e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—atherosclerosis	2.21e-06	2.07e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—atherosclerosis	2.2e-06	2.07e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—atherosclerosis	2.08e-06	1.96e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.04e-06	1.91e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—atherosclerosis	1.7e-06	1.6e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—atherosclerosis	1.57e-06	1.47e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—atherosclerosis	1.55e-06	1.46e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—atherosclerosis	1.02e-06	9.62e-06	CbGpPWpGaD
